UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000014929
Receipt number R000017372
Scientific Title The efficacy of topical NSAIDs for anti-VEGF therapy for vitreomacular disease
Date of disclosure of the study information 2014/08/23
Last modified on 2018/01/14 16:24:20

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The efficacy of topical NSAIDs for anti-VEGF therapy for vitreomacular disease

Acronym

The efficacy of topical NSAID

Scientific Title

The efficacy of topical NSAIDs for anti-VEGF therapy for vitreomacular disease

Scientific Title:Acronym

The efficacy of topical NSAID

Region

Japan


Condition

Condition

retinal vein occlusion
diabetic retinopathy
age related macular degeneration

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess the effectiveness of topical NSAID for anti-VEGF treatment in vitreomacular disease

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Progression of visual acuity
Regression of macular thickness

Key secondary outcomes

frequecy of anti-VEGF treatment


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Topical NSAID for 1 year follow up

Interventions/Control_2

Topical artificial tear as placebo for 1 year follow up

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Macular edema with diabetic retinopathy, retinal vein occlusion, or age-related macular degeneration.
central macular thickness more than 400 mirometer.
logMAR visual acuity between 0.5 and 1
treatment naive case
senseitive to anti-VEGF therapy

Key exclusion criteria

macular ischemia
ocular inflammation
systemic disorder other than hypertension and hypercholesterolaemia

Target sample size

200


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masahiko Shimura

Organization

Tokyo Medical University Hachioji Medical center

Division name

Department of Ophthalmology

Zip code


Address

1163 Tate-machi, Hachioji Tokyo

TEL

0426655611

Email

masahiko@v101.vaio.ne.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kanako Yasuda

Organization

Tokyo Medical University Hachioji Medical Center

Division name

Ophthalmology

Zip code


Address

1163 Tate-machi, Hachioji Tokyo

TEL

0426655611

Homepage URL


Email

kana6723@yahoo.co.jp


Sponsor or person

Institute

NTT East japan Tohoku Hospital

Institute

Department

Personal name



Funding Source

Organization

NTT East japan Tohoku Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

NTT東日本東北病院(宮城県)
東京医科大学八王子医療センター(東京都)


Other administrative information

Date of disclosure of the study information

2014 Year 08 Month 23 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

https://www.ncbi.nlm.nih.gov/pubmed/27306783

Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2011 Year 04 Month 01 Day

Date of IRB


Anticipated trial start date

2014 Year 08 Month 24 Day

Last follow-up date

2016 Year 03 Month 31 Day

Date of closure to data entry

2016 Year 04 Month 30 Day

Date trial data considered complete

2016 Year 04 Month 30 Day

Date analysis concluded

2016 Year 04 Month 30 Day


Other

Other related information



Management information

Registered date

2014 Year 08 Month 23 Day

Last modified on

2018 Year 01 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017372


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name